Drugs Controller General of India briefs the media on COVID-19 vaccine
The Health Ministry on Saturday conducted a nationwide mock drill at 285 session sites to test the end-to-end planned operations and the mechanism that has been set up to ensure smooth conduct of the COVID-19 vaccination
New Delhi: The Drugs Controller General of India briefed media on Coronavirus vaccine on Coronavirus vaccine.
#WATCH: Drugs Controller General of India briefs the media on COVID-19 vaccine. https://t.co/0PhAeVzOgC
— ANI (@ANI) January 3, 2021
Earlier on Saturday, the Subject Expert Committee (SEC) of the Central Drugs Standards Control Organisation made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of the Serum Institute of India (SII) and Bharat Biotech’s vaccines.
As per an official release, the SEC met on Friday and Saturday and made its recommendations in respect of the accelerated approval process request of the SII, Bharat Biotech International Ltd as well as about phase-III trials of Cadila Healthcare Ltd.
Meanwhile, COVID-19 vaccination drive based on election process planned down to the booth level and 96,000 vaccinators have been trained so far, said Union Health Minister Dr Harsh Vardhan.
“Vaccination drive has been based on election process planned down to the booth level. Over 57,000 participants across 719 districts have completed training. 96,000 vaccinators have been trained so far,” the Minister tweeted. The Minister had on Saturday visited two mock vaccination sites in Delhi to review the dry run drill for administering COVID-19 vaccine.
